Dallas - Low-dose Propecia (finasteride, Merck), used to treat hair loss, appears to suppress prostate specific antigen (PSA) levels, which could skew results of prostate cancer tests, researchers say.
Phase 3 Data for Bimekizumab Shows Well Maintained Response
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
FDA Approves Adalimumab-Adaz High-Concentration Formulation
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Skin Barrier 101: Keep Up with What Your Patients Are Reading
Oral Ivarmacitinib Demonstrates Significant Atopic Dermatitis Improvement
2 Clarke Drive Cranbury, NJ 08512